Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study.

ABSTRACT:

Background

Among patients with stage I breast cancer, there is significant uncertainty concerning the optimal threshold at which to consider chemotherapy, and when considered, there is controversy regarding whether to consider non-intensive versus intensive regimens. The authors examined the types and costs of adjuvant chemotherapy received among patients with stage I breast cancer.

Methods

The current study was a prospective cohort study including patients with stage I breast cancer who were treated at a National Comprehensive Cancer Network center from 2000 through 2009. Stage was defined according to the version of the American Joint Committee on Cancer Staging Manual applicable at the time of diagnosis. Stratifying by human epidermal growth factor receptor 2 (HER2), the

SUBMITTER: Vaz-Luis I 

PROVIDER: S-EPMC4457605 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature